Venue & Travel
- Programme Committee
Exhibiting Your Company
Sponsors of Obesity Update 2020
Do you want to exhibit your company or sponsor the conference in 2021?How to sponsor Obesity Update
2020 Headline Sponsor
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care.
This heritage has given us experience and capabilities that also enable us to help people with obesity, haemophilia, growth disorders and other serious chronic diseases.
Headquartered in Denmark, Novo Nordisk employs approximately 41,600 people in 80 countries and markets its products in more than 170 countries.
For more information, visit novonordisk.co.uk
Founded in 1967, the ASO has become the UK’s foremost charitable organisation dedicated to the understanding, prevention and treatment of obesity.
The ASO aims to develop an understanding of obesity through the pursuit of excellence in research and education, the acilitation of contact between individuals and organisations, and the promotion of action to prevent and treat
The ASO is also a member of the Obesity Health Alliance (OHA), a coalition of over 30 charities, medical royal colleges and campaign groups who have joined together to fight obesity.
InBody are the global leaders in body composition analysis, providing accurate and reliable body composition and blood pressure results to both patients and professionals.
InBody provide an essential tool used in health and wellbeing assessments, giving healthcare professionals an innovative tool to enhance their patient care
Body composition is essential for understanding the patient’s physiological makeup and guiding targeted therapies to enhance the success of weight management programs.
InBody devices are non-invasive and convenient, making it the ideal tool to implement into clinical practice.
The InBody test provides comprehensive results that can be used to educate and engage the patient as well as track health improvements throughout patient interventions.
In less than 60 seconds, the InBody test provides easy-to-understand, accurate and objective measurements to evaluate health risks and monitor progress. Bariatric professionals can use the InBody to:
- Assess muscle-fat balance and visceral fat for comprehensive health risk assessments
- Identify fluid imbalances related to inflammation or underlying disease
- Monitor changes to determine efficacy of treatments and further guide health recommendations to ensure long-term success.
The Society for Endocrinology is the UK home of endocrinology.
We bring together the global endocrine community to share ideas and advance our discipline. As a membership organisation, we support scientists, clinicians and nurses who work with hormones throughout their careers. We also engage policymakers, journalists, patients and the public with hormone science to encourage informed health decisions, and to demonstrate the value of endocrinology to the wider world.
Come to the stand to talk about Society membership, the available grants and our upcoming events.
World Obesity Federation represents professional members of the scientific, medical and research communities from over 50 regional and national obesity associations.
Through our membership we create a global community of organisations dedicated to solving the problems of obesity. Our mission is to lead and drive global efforts to reduce, prevent and treat obesity.
There are several ways we work with our member organisations as well as other professional bodies. These range from roundtables we convene to discuss policy, advocacy training for patients, educational training for healthcare professionals and communication campaigns to amplify the work we are doing to a wider audience – to name a few.
We advocate with governments, international and national health bodies, civil society organisations, and other key stakeholders around the world to change the narrative around obesity and achieve the political recognition which it deserves.